Since the 90ies we have specialized in „Translational Sciences” – Implementing projects across traditional intersections from research to medicines ready for the market.
The PMD Team around Prof. Christian Noe is endowed with a long record of experience in discovery, development and production of highly active medicines on a broad international level.
Christian Noe was born in Austria, studied Chemistry at the University of Technology in Vienna (promotion “sub auspiciis praesidentis”) and Pharmacy at the University of Vienna. He was post-doc at the ETH Zürich with Albert Eschenmoser.
After his Habilitation in 1982 he became Group Leader at the Department of Organic Chemistry of the TU Vienna. In 1989, he was rewarded an Austrian Centre of Excellence (“Christian Doppler Laboratory”) as one of the first recipients. In 1991, he was appointed C4-Professor and Chairman of the Department of Medicinal Chemistry of the Goethe-University Frankfurt. There his focus of interest moved to biomedicine.
In 1999 he returned to Austria to take the position of Ordinarius of Medicinal Chemistry at the University of Vienna until 2012. He was Dean at both Universities. During his period as Dean in Vienna from 2002 to 2008 he was heavily involved into the strategic development and restructuring of the University and became the first Dean of the newly created Faculty of Life Sciences.
From 2005 to 2007 he was President of the European Federation of Pharmaceutical Sciences (EUFEPS). He was elected Member and Chairman of the Scientific Committee of the Innovative Medicines Initiative, a joint Undertaking of the European Commission with EFPIA during its first phase from 2009 to 2914. (IMI-JU was then the largest Public-Private-Partnership in Life Sciences worldwide.)
For many years Christian Noe served UNIDO (United Nations Industrial Development Organisation) as an Expert in the field of pharmaceutical industry. From 2012 to 2016 he was Member of the Standing Advisory Group for Nuclear Applications (SAGNA) of the International Atomic Energy Agency (IAEA).
After his retirement from University, Christian Noe has continued to follow his research interests in the field of Drug R&D within the frame of start-up companies. He received the PSWC Research Achievement Award of the Pharmaceutical Sciences World Congress in 2010. He is Corresponding Member of the Austrian Academy of Sciences and Honorary Member of the Hungarian Academy of Sciences.
Christian Noe is father of seven children.
Marion Noe was born in Augsburg/Germany and grew up in Austria. She studied Chemical Engineering at the Vienna University of Technology finishing her study with the degrees of “Master of chemical engineering” (Dipl.-Ing.) and “Doctor of Technological Sciences”. In 1987 she became assistant professor at the Institute of Organic Chemistry of the Vienna University of Technology. She was also post-doctoral researcher at the Christian Doppler Laboratory for Chiral Compounds working in the field of bio-organic chemistry. There, apart from stereochemical research related to stereo-electronic effects and chiral recognition, she had the opportunity to gain experience in medicinal chemistry (design of NMDA receptor antagonists, EPC and API synthesis).
In parallel to chemistry, Marion Noe studied medicine at the University of Vienna to finish with the degree of Doctor of Medicine in 1992. After an internship at the Central Hospital (LKH) Klagenfurt she became Resident at the Institute of Pathology, Central Hospital Darmstadt (Germany) in 1997. She started her specialization in Gynaecology and Obstetrics as Resident at the Department of Gynaecology and Obstetrics of the Klinikum Darmstadt, which is an Academic Teaching Hospital to the Universities of Frankfurt and Heidelberg/Mannheim. There she developed her scientific profile as a specialist in gynaecological endocrinology and reproductive medicine. She revealed new findings on uterine physiology, on the role of stem cells in uterine function and above all on cellular and biochemical mechanisms influencing uterine motility. She also worked on the role of cell adhesion in physiological and pathological conditions of adenomyosis and endometriosis.
After her return to Austria in 1999, Marion Noe became Resident at the Department for Gynecology and Obstetrics at the University Hospital Vienna and later at the neonatal intensive care unit of the pediatric clinic at the University Hospital Vienna (as complementary field). She sharpened her profile as specialist in reproductive medicine at the Department for Gynaecology and Obstetrics at the University Hospital Vienna and became Deputy Medical Director at the Kinderwunschzentrum Döbling. From 2012, she is Gynecologist in her private research focused practice.
From 2004 on, the focus of activities of Marion Noe increasingly shifted to management activities in the field of Pharma R&D. She founded the start-up company ProFem GmbH, an R&D company dealing with unmet medical need in female health. Her business plan received the “Best of Biotech” Award in 2010 and was the best submitted project in the ZIT “FemPower”call in 2012. Presently, the first ProFem project Candiplus is in clinical phase 3. Along with the focus of this project on chronic infections, Marion Noe has become an expert in gynaecological infectiology, in addition.
Over the years, Marion Noe has gained a broad range of expertise in the field of biotech pharma, ranging from financial administration (controlling, budgeting, fund raising), to project management including both preclinical drug development (API-production, GMP documentation) and clinical development. She has, last nor least, broad experience in general management of a start-up company as a CEO.
Marion Noe is mother of five daughters.
Stefan Sladeček was born and grew up in Vienna, Austria. He studied Molecular Biology in Vienna and then completed his PhD in Biochemistry in Basel, Switzerland, where he worked on signal transduction and cytoskeletal rearrangement at the postsynaptic neuro-muscular junction. Still in Switzerland, he then gained life science industry experience as a project leader in the renowned medical communication agency Ogilvy Healthworld, and later as Senior Analyst/Consultant in the specialized life science strategy consulting firm Health Advances.
After his return to Austria, Stefan held several position with increasing responsibility in both the pharmaceutical industry (Chiesi, Novartis) and the MedTech industry. Immediately prior to joining PMD, he was employed as Head of Market Access at Roche Diagnostics, the worldwide leader in in-vitro diagnostics.
In addition, he undertook several further educations such as formal trainings in market access, HTA & health economics, lobbying & governmental affairs, as a clinical investigator, in intellectual property and as start-up founder. He was repeatedly an invited speaker and lecturer at international health-economic events.
Over the years, Stefan has gained a wide range of expertise in the life science industry, ranging from value communication, policy shaping, market access and reimbursement, over marketing and medical writing, to product and portfolio strategy, forecasting and finally people and project management.
Stefan is an avid sportsman, outdoor-enthusiast and father of one son.